Literature DB >> 4052359

Ectopic intracranial retinoblastoma in childhood.

J E Kingston, P N Plowman, J L Hungerford.   

Abstract

Twelve out of a series of 630 children with retinoblastoma, treated in the ocular oncology units at St Bartholomew's and Moorfields Eye Hospitals during the past 30 years, have developed ectopic intracranial retinoblastoma. The ectopic tumour occurred in the pineal region in eight children and in the suprasellar region in four. Ten patients had bilateral retinoblastoma, one unilateral disease, and one child presented with an isolated suprasellar tumour but no evidence of retinal disease. The interval from the initial diagnosis of retinoblastoma to the development of ectopic intracranial disease ranged from 4 to 70 months, median 34 months. Methods of treatment for the ectopic tumour varied, but all 12 children died with a median survival of only 8 months following the diagnosis of ectopic retinoblastoma. Subsequent spread of tumour to other sites within the central nervous system proved to be the most frequent cause of death. Ectopic intracranial retinoblastoma is a potentially curable neoplasm, but it requires adequate therapy to the whole neuraxis as well as high dose equivalent radiotherapy to the primary tumour.

Entities:  

Mesh:

Year:  1985        PMID: 4052359      PMCID: PMC1040731          DOI: 10.1136/bjo.69.10.742

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Retinoblastoma and intracranial malignancy.

Authors:  F A Jakobiec; M O Tso; L E Zimmerman; P Danis
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

2.  Pinealoblastoma with retinoblastomatous differentiation.

Authors:  S Z Stefanko; W A Manschot
Journal:  Brain       Date:  1979-06       Impact factor: 13.501

3.  Trilateral retinoblastoma.

Authors:  J L Bader; R W Miller; A T Meadows; L E Zimmerman; L A Champion; P A Voûte
Journal:  Lancet       Date:  1980-09-13       Impact factor: 79.321

4.  Tumors of the pineal and suprasellar region: Childrens Cancer Study Group treatment results 1960--1975: a report from Childrens Cancer Study Group.

Authors:  W M Wara; R D Jenkin; A Evans; I Ertel; R Hittle; J Ortega; C B Wilson; D Hammond
Journal:  Cancer       Date:  1979-02       Impact factor: 6.860

5.  The value of myelography in the management of childhood medulloblastoma.

Authors:  M Deutsch; D H Reigel
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

6.  Bilateral retinoblastoma with ectopic intracranial retinoblastoma: trilateral retinoblastoma.

Authors:  J L Bader; A T Meadows; L E Zimmerman; L B Rorke; P A Voute; L A Champion; R W Miller
Journal:  Cancer Genet Cytogenet       Date:  1982-03

Review 7.  The separation of pineocytoma from pineoblastoma.

Authors:  A Borit; W Blackwood; W G Mair
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

8.  Midline pineal tumors and suprasellar germinomas: highly curable by irradiation.

Authors:  D I Sung; L Harisiadis; C H Chang
Journal:  Radiology       Date:  1978-09       Impact factor: 11.105

9.  The trilateral retinoblastoma syndrome.

Authors:  J Dudgeon; W R Lee
Journal:  Trans Ophthalmol Soc U K       Date:  1983
  9 in total
  10 in total

Review 1.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Trilateral retinoblastoma: A systematic review of 211 cases.

Authors:  Ryuya Yamanaka; Azusa Hayano; Yasuo Takashima
Journal:  Neurosurg Rev       Date:  2017-08-16       Impact factor: 3.042

3.  Neuronal and glial properties of a murine transgenic retinoblastoma model.

Authors:  T Kivelä; I Virtanen; D M Marcus; J M O'Brien; J L Carpenter; E Brauner; A Tarkkanen; D M Albert
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

4.  Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival.

Authors:  B M Sanders; G J Draper; J E Kingston
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

5.  Globe conserving treatment of the only eye in bilateral retinoblastoma.

Authors:  V Lee; J L Hungerford; C Bunce; F Ahmed; J E Kingston; P N Plowman
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 6.  Retinoblastoma.

Authors:  Isabelle Aerts; Livia Lumbroso-Le Rouic; Marion Gauthier-Villars; Hervé Brisse; François Doz; Laurence Desjardins
Journal:  Orphanet J Rare Dis       Date:  2006-08-25       Impact factor: 4.123

7.  The RB1 gene mutation in a child with ectopic intracranial retinoblastoma.

Authors:  Z Onadim; A J Woolford; J E Kingston; J L Hungerford
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.

Authors:  Kathleen M Schieffer; Alexander Z Feldman; Esko A Kautto; Sean McGrath; Anthony R Miller; Maria Elena Hernandez-Gonzalez; Stephanie LaHaye; Katherine E Miller; Daniel C Koboldt; Patrick Brennan; Benjamin Kelly; Amy Wetzel; Vibhuti Agarwal; Margaret Shatara; Suzanne Conley; Diana P Rodriguez; Rolla Abu-Arja; Ala Shaikhkhalil; Matija Snuderl; Brent A Orr; Jonathan L Finlay; Diana S Osorio; Annie I Drapeau; Jeffrey R Leonard; Christopher R Pierson; Peter White; Vincent Magrini; Elaine R Mardis; Richard K Wilson; Catherine E Cottrell; Daniel R Boué
Journal:  Acta Neuropathol Commun       Date:  2021-04-07       Impact factor: 7.801

9.  Second primary neoplasms in patients with retinoblastoma.

Authors:  G J Draper; B M Sanders; J E Kingston
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

10.  Patterns of multiple primary tumours in patients treated for cancer during childhood.

Authors:  J E Kingston; M M Hawkins; G J Draper; H B Marsden; L M Kinnier Wilson
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.